1. Home
  2. JAGX vs NCPL Comparison

JAGX vs NCPL Comparison

Compare JAGX & NCPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAGX
  • NCPL
  • Stock Information
  • Founded
  • JAGX 2013
  • NCPL 1984
  • Country
  • JAGX United States
  • NCPL United States
  • Employees
  • JAGX N/A
  • NCPL N/A
  • Industry
  • JAGX Biotechnology: Pharmaceutical Preparations
  • NCPL Investment Managers
  • Sector
  • JAGX Health Care
  • NCPL Finance
  • Exchange
  • JAGX Nasdaq
  • NCPL Nasdaq
  • Market Cap
  • JAGX 8.1M
  • NCPL 4.3M
  • IPO Year
  • JAGX N/A
  • NCPL N/A
  • Fundamental
  • Price
  • JAGX $8.51
  • NCPL $1.92
  • Analyst Decision
  • JAGX
  • NCPL
  • Analyst Count
  • JAGX 0
  • NCPL 0
  • Target Price
  • JAGX N/A
  • NCPL N/A
  • AVG Volume (30 Days)
  • JAGX 246.2K
  • NCPL 42.6K
  • Earning Date
  • JAGX 05-16-2025
  • NCPL 03-17-2025
  • Dividend Yield
  • JAGX N/A
  • NCPL N/A
  • EPS Growth
  • JAGX N/A
  • NCPL N/A
  • EPS
  • JAGX N/A
  • NCPL N/A
  • Revenue
  • JAGX $11,689,000.00
  • NCPL $812,612.00
  • Revenue This Year
  • JAGX $38.22
  • NCPL N/A
  • Revenue Next Year
  • JAGX $39.96
  • NCPL $101.16
  • P/E Ratio
  • JAGX N/A
  • NCPL N/A
  • Revenue Growth
  • JAGX 19.75
  • NCPL N/A
  • 52 Week Low
  • JAGX $4.02
  • NCPL $1.41
  • 52 Week High
  • JAGX $502.50
  • NCPL $22.82
  • Technical
  • Relative Strength Index (RSI)
  • JAGX 46.54
  • NCPL 50.02
  • Support Level
  • JAGX $10.41
  • NCPL $1.75
  • Resistance Level
  • JAGX $13.20
  • NCPL $2.15
  • Average True Range (ATR)
  • JAGX 1.90
  • NCPL 0.10
  • MACD
  • JAGX 0.07
  • NCPL -0.01
  • Stochastic Oscillator
  • JAGX 29.02
  • NCPL 42.50

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

About NCPL Netcapital Inc.

Netcapital Inc is a financial technology company. The company facilitates the growth of private companies by providing fundraising services and other consulting services. The company's online private investment platform connects entrepreneurs and investors, enabling companies to raise capital digitally. The Company operates in a single operating segment, which is the provision of fintech services.

Share on Social Networks: